Inventor · disambiguated record
Aberra Fura
Also filed as: FURA ABERRA
9 granted patents·4 pending applications·168 citations·filing 1995–2021
89Inventor score
Top patents by PatentIndex Score
13 records- 0194US5750565ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted May 12, 1998·66 cites·29 claims
- 0290US7141578B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 28, 2006·17 cites·14 claims
- 0390US5703093ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted Dec 30, 1997·55 cites·22 claims
- 0482US7517904B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Apr 14, 2009·1 cites·3 claims
- 0574US7655689B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Feb 2, 2010·1 cites·13 claims
- 0668US5681966ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted Oct 28, 1997·10 cites·50 claims
- 0766US6201016B1Compounds and methods for the treatment of cardiovascular, inflammatory and immune disordersCYTOMED INC·Filed 1995·Granted Mar 13, 2001·12 cites·15 claims
- 0854US6025384ACompounds and methods for the treatment of cardiovascular, inflammatory and immune disordersLEUKOSITE INC·Filed 1998·Granted Feb 15, 2000·4 cites·17 claims
- 0952US2023331860A1Method of Treating an Autoimmune Disease with Antagonistic CD40 Monoclonal AntibodiesBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1051US2004077605A1Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionFiled 2002·Application pending·0 cites
- 1146US6569895B1Compounds and methods for the treatment of cardiovascular, inflammatory and immune disordersMILLENNIUM PHARM INC·Filed 1999·Granted May 27, 2003·2 cites·21 claims
- 1240US2003055084A1Pharmaceutical compounds and methods of use thereofMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 1338US2004176324A1Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →